- Home
- OABI vs FFA Comparison
OABI vs FFA Comparison
Compare OABI & FFA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OABI
- FFA
- Stock Information
- Founded
- OABI 2012
- FFA 2004
- Country
- OABI United States
- FFA United States
- Employees
- OABI N/A
- FFA N/A
- Industry
- OABI Biotechnology: Pharmaceutical Preparations
- FFA Investment Managers
- Sector
- OABI Health Care
- FFA Finance
- Exchange
- OABI Nasdaq
- FFA Nasdaq
- Market Cap
- OABI 388.5M
- FFA 411.2M
- IPO Year
- OABI N/A
- FFA N/A
- Fundamental
- Price
- OABI $3.22
- FFA $20.88
- Analyst Decision
- OABI Strong Buy
- FFA
- Analyst Count
- OABI 4
- FFA 0
- Target Price
- OABI $9.00
- FFA N/A
- AVG Volume (30 Days)
- OABI 448.8K
- FFA 26.1K
- Earning Date
- OABI 11-12-2024
- FFA 01-01-0001
- Dividend Yield
- OABI N/A
- FFA 6.72%
- EPS Growth
- OABI N/A
- FFA N/A
- EPS
- OABI N/A
- FFA N/A
- Revenue
- OABI $20,409,000.00
- FFA N/A
- Revenue This Year
- OABI N/A
- FFA N/A
- Revenue Next Year
- OABI $78.61
- FFA N/A
- P/E Ratio
- OABI N/A
- FFA N/A
- Revenue Growth
- OABI N/A
- FFA N/A
- 52 Week Low
- OABI $3.16
- FFA $15.84
- 52 Week High
- OABI $6.55
- FFA $19.30
- Technical
- Relative Strength Index (RSI)
- OABI 32.70
- FFA 58.20
- Support Level
- OABI $3.16
- FFA $20.03
- Resistance Level
- OABI $3.29
- FFA $20.63
- Average True Range (ATR)
- OABI 0.13
- FFA 0.28
- MACD
- OABI -0.02
- FFA 0.05
- Stochastic Oscillator
- OABI 9.09
- FFA 90.08
About OABI OmniAb Inc.
OmniAb Inc offers therapeutic antibody discovery technologies. The company focuses on enabling the rapid development of therapeutics by pushing the frontiers of drug discovery technologies. Its technology platform is designed to enable the efficient discovery of high-quality, fully human antibodies for a wide range of diseases. The heart of the OmniAb technology platform is the Biological Intelligence of its proprietary transgenic animals, including OmniRat, OmniMouse, and OmniChicken, that have been genetically modified to generate antibodies with human sequences which are naturally optimized through in vivo affinity maturation.
About FFA First Trust Enhanced Equity Income Fund
First Trust Enhanced Equity Income Fund is a diversified, closed-end management investment company. Its investment objective is to provide a high level of current income and gains and, to a lesser extent, capital appreciation. The Fund pursues its investment objective by investing in a diversified portfolio of equity securities.